What have we learned from the IL28 receptor knockout mouse?
暂无分享,去创建一个
[1] S. Günther,et al. Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections , 2010, Journal of Virology.
[2] S. Paludan,et al. Expression of Type III Interferon (IFN) in the Vaginal Mucosa Is Mediated Primarily by Dendritic Cells and Displays Stronger Dependence on NF-κB than Type I IFNs , 2010, Journal of Virology.
[3] Thomas Berg,et al. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy , 2009, Nature Genetics.
[4] A. Koike,et al. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C , 2009, Nature Genetics.
[5] Jacques Fellay,et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.
[6] J. Renauld,et al. Interferon-λ Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses , 2008, PLoS pathogens.
[7] T. Michiels,et al. IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo , 2008, PLoS pathogens.
[8] U. Jensen,et al. An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity1 , 2008, The Journal of Immunology.
[9] G. Kochs,et al. The Mx1 Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses , 2007, Journal of Virology.
[10] S. Smirnov,et al. Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus , 2007, Proceedings of the National Academy of Sciences.
[11] G. Uzé,et al. IL-28 and IL-29: newcomers to the interferon family. , 2007, Biochimie.
[12] A. Nielsen,et al. Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases , 2007, Journal of Virology.
[13] J. Casanova,et al. Induction of MxA Gene Expression by Influenza A Virus Requires Type I or Type III Interferon Signaling , 2007, Journal of Virology.
[14] G. Kochs,et al. Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. , 2007, The Journal of general virology.
[15] G. Gallagher,et al. Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response , 2007, Genes and Immunity.
[16] S. Akira,et al. Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism* , 2007, Journal of Biological Chemistry.
[17] G. Kochs,et al. Protective Role of Beta Interferon in Host Defense against Influenza A Virus , 2006, Journal of Virology.
[18] Pallavur Sivakumar,et al. Interleukin‐29 uses a type 1 interferon‐like program to promote antiviral responses in human hepatocytes , 2006, Hepatology.
[19] Stephen T Holgate,et al. Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.
[20] S. Paludan,et al. Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo , 2006, Journal of Virology.
[21] S. Smirnov,et al. Characterization of the mouse IFN-λ ligand-receptor system: IFN-λs exhibit antitumor activity against B16 melanoma , 2006 .
[22] S. Brand,et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[23] S. Kotenko,et al. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. , 2005, The Journal of general virology.
[24] F. Chisari,et al. Lambda Interferon Inhibits Hepatitis B and C Virus Replication , 2005, Journal of Virology.
[25] J. Renauld,et al. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. , 2004, The Journal of biological chemistry.
[26] E. Coccia,et al. Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cells , 2004, European journal of immunology.
[27] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[28] J. Sutcliffe,et al. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation , 1988, Molecular and cellular biology.
[29] M. Boniotto,et al. Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29) , 2007, Genes and Immunity.
[30] A. Lewis-Antes,et al. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex , 2003, Nature Immunology.
[31] Scott R. Presnell,et al. IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.
[32] Interferon- (cid:1) –treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells , 2022 .